Body 0 4 0 4 B-bmi
mass 5 9 5 9 I-bmi
index 10 15 10 15 I-bmi
( 16 17 16 17 I-bmi
BMI 17 20 17 20 I-bmi
) 20 21 20 21 I-bmi
> 22 23 22 23 O
= 23 24 23 24 O
25 25 27 25 27 B-lower_bound
kg 28 30 28 30 I-lower_bound
/ 30 31 30 31 I-lower_bound
m^2 31 34 31 34 I-lower_bound

Current 0 7 35 42 O
, 7 8 42 43 O
recent 9 15 44 50 O
( 16 17 51 52 O
< 17 18 52 53 O
1 19 20 54 55 B-upper_bound
year 21 25 56 60 I-upper_bound
) 25 26 60 61 O
, 26 27 61 62 O
or 28 30 63 65 O
planning 31 39 66 74 O
to 40 42 75 77 O
join 43 47 78 82 O
a 48 49 83 84 O
weight 50 56 85 91 O
loss 57 61 92 96 O
program 62 69 97 104 O
or 70 72 105 107 O
take 73 77 108 112 O
appetite 78 86 113 121 O
suppressants 87 99 122 134 O

Doctor 0 6 135 141 O
of 7 9 142 144 O
medicine 10 18 145 153 O
( 19 20 154 155 O
MD 20 22 155 157 O
) 22 23 157 158 O
confirmed 24 33 159 168 O
cognitive 34 43 169 178 B-chronic_disease
impairment 44 54 179 189 I-chronic_disease

Histologically 0 14 190 204 O
confirmed 15 24 205 214 O
adenocarcinoma 25 39 215 229 B-cancer
of 40 42 230 232 I-cancer
the 43 46 233 236 I-cancer
prostate 47 55 237 245 I-cancer
, 55 56 245 246 O
clinically 57 67 247 257 O
localized 68 77 258 267 O
, 77 78 267 268 O
low 79 82 269 272 O
or 83 85 273 275 O
low 86 89 276 279 O
- 89 90 279 280 O
intermediate 90 102 280 292 O
risk 103 107 293 297 O
disease 108 115 298 305 O
( 116 117 306 307 O
T1C 117 120 307 310 B-clinical_variable
/ 120 121 310 311 O
T2a 121 124 311 314 B-clinical_variable
, 124 125 314 315 O
Gleason 126 133 316 323 B-clinical_variable
= 134 135 324 325 O
< 135 136 325 326 O
7 137 138 327 328 B-upper_bound
[ 139 140 329 330 O
3 140 141 330 331 O
+ 141 142 331 332 O
4 142 143 332 333 O
] 143 144 333 334 O
, 144 145 334 335 O
prostate 146 154 336 344 B-clinical_variable
- 154 155 344 345 I-clinical_variable
specific 155 163 345 353 I-clinical_variable
antigen 164 171 354 361 I-clinical_variable
[ 172 173 362 363 I-clinical_variable
PSA 173 176 363 366 I-clinical_variable
] 176 177 366 367 I-clinical_variable
< 178 179 368 369 O
20 180 182 370 372 B-upper_bound
) 182 183 372 373 O

Insulin 0 7 374 381 B-chronic_disease
dependent 8 17 382 391 I-chronic_disease
diabetes 18 26 392 400 I-chronic_disease
mellitus 27 35 401 409 I-chronic_disease
( 36 37 410 411 I-chronic_disease
DM 37 39 411 413 I-chronic_disease
) 39 40 413 414 I-chronic_disease
and/or 41 47 415 421 O
metformin 48 57 422 431 B-treatment
use 58 61 432 435 O

Primary 0 7 436 443 B-treatment
treatment 8 17 444 453 I-treatment
is 18 20 454 456 O
active 21 27 457 463 B-treatment
surveillance 28 40 464 476 I-treatment
( 41 42 477 478 I-treatment
AS 42 44 478 480 I-treatment
) 44 45 480 481 I-treatment
with 46 50 482 486 I-treatment
planned 51 58 487 494 I-treatment
annual 59 65 495 501 I-treatment
surveillance 66 78 502 514 I-treatment
biopsies 79 87 515 523 I-treatment

Significant 0 11 524 535 O
cardiovascular 12 26 536 550 B-chronic_disease
disease 27 34 551 558 I-chronic_disease
precluding 35 45 559 569 O
an 46 48 570 572 O
exercise 49 57 573 581 O
program 58 65 582 589 O
, 65 66 589 590 O
including 67 76 591 600 O
recent 77 83 601 607 O
( 84 85 608 609 O
within 85 91 609 615 O
6 92 93 616 617 B-upper_bound
months 94 100 618 624 I-upper_bound
) 100 101 624 625 O
myocardial 102 112 626 636 B-chronic_disease
infarction 113 123 637 647 I-chronic_disease
or 124 126 648 650 O
stroke 127 133 651 657 B-chronic_disease
, 133 134 657 658 O
pulmonary 135 144 659 668 B-chronic_disease
edema 145 150 669 674 I-chronic_disease
, 150 151 674 675 O
myocarditis 152 163 676 687 B-chronic_disease
, 163 164 687 688 O
pericarditis 165 177 689 701 B-chronic_disease
, 177 178 701 702 O
unstable 179 187 703 711 B-chronic_disease
angina 188 194 712 718 I-chronic_disease
, 194 195 718 719 O
pulmonary 196 205 720 729 O
embolism 206 214 730 738 O
/ 214 215 738 739 O
deep 215 219 739 743 O
venous 220 226 744 750 O
thrombosis 227 237 751 761 O
( 238 239 762 763 O
PE 239 241 763 765 O
/ 241 242 765 766 O
DVT 242 245 766 769 O
) 245 246 769 770 O
, 246 247 770 771 O
uncontrolled 248 260 772 784 O
hypertension 261 273 785 797 B-chronic_disease
( 274 275 798 799 O
systolic 275 283 799 807 B-clinical_variable
blood 284 289 808 813 I-clinical_variable
pressure 290 298 814 822 I-clinical_variable
[ 299 300 823 824 I-clinical_variable
SBP 300 303 824 827 I-clinical_variable
] 303 304 827 828 I-clinical_variable
> 305 306 829 830 O
200 307 310 831 834 B-lower_bound
; 310 311 834 835 O
diastolic 312 321 836 845 B-clinical_variable
blood 322 327 846 851 I-clinical_variable
pressure 328 336 852 860 I-clinical_variable
[ 337 338 861 862 I-clinical_variable
DBP 338 341 862 865 I-clinical_variable
] 341 342 865 866 I-clinical_variable
> 343 344 867 868 O
110 345 348 869 872 B-lower_bound
) 348 349 872 873 O
, 349 350 873 874 O
uncontrolled 351 363 875 887 O
arrhythmia 364 374 888 898 B-chronic_disease
, 374 375 898 899 O
heart 376 381 900 905 B-chronic_disease
failure 382 389 906 913 I-chronic_disease

Steroid 0 7 914 921 B-treatment
hormone 8 15 922 929 I-treatment
use 16 19 930 933 O
( 20 21 934 935 O
antiandrogen 21 33 935 947 B-treatment
therapy 34 41 948 955 I-treatment
[ 42 43 956 957 I-treatment
ADT 43 46 957 960 I-treatment
] 46 47 960 961 I-treatment
) 47 48 961 962 O
within 49 55 963 969 O
the 56 59 970 973 O
past 60 64 974 978 B-upper_bound
12 65 67 979 981 I-upper_bound
months 68 74 982 988 I-upper_bound

